IRIS Accounts Production v25.1.3.33 12274820 director 1.2.24 31.1.25 31.1.25 0 0 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh122748202024-01-31122748202025-01-31122748202024-02-012025-01-31122748202023-01-31122748202023-02-012024-01-31122748202024-01-3112274820ns15:EnglandWales2024-02-012025-01-3112274820ns14:PoundSterling2024-02-012025-01-3112274820ns10:Director12024-02-012025-01-3112274820ns10:PrivateLimitedCompanyLtd2024-02-012025-01-3112274820ns10:SmallEntities2024-02-012025-01-3112274820ns10:AuditExempt-NoAccountantsReport2024-02-012025-01-3112274820ns10:SmallCompaniesRegimeForDirectorsReport2024-02-012025-01-3112274820ns10:SmallCompaniesRegimeForAccounts2024-02-012025-01-3112274820ns10:FullAccounts2024-02-012025-01-3112274820ns10:CompanySecretary12024-02-012025-01-3112274820ns10:RegisteredOffice2024-02-012025-01-3112274820ns5:CurrentFinancialInstruments2025-01-3112274820ns5:CurrentFinancialInstruments2024-01-3112274820ns5:Non-currentFinancialInstruments2025-01-3112274820ns5:Non-currentFinancialInstruments2024-01-3112274820ns5:ShareCapital2025-01-3112274820ns5:ShareCapital2024-01-3112274820ns5:RetainedEarningsAccumulatedLosses2025-01-3112274820ns5:RetainedEarningsAccumulatedLosses2024-01-3112274820ns5:FurnitureFittings2024-02-012025-01-3112274820ns5:ComputerEquipment2024-02-012025-01-3112274820ns5:FurnitureFittings2024-01-3112274820ns5:ComputerEquipment2024-01-3112274820ns5:FurnitureFittings2025-01-3112274820ns5:ComputerEquipment2025-01-3112274820ns5:FurnitureFittings2024-01-3112274820ns5:ComputerEquipment2024-01-3112274820ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3112274820ns5:WithinOneYearns5:CurrentFinancialInstruments2024-01-31
REGISTERED NUMBER: 12274820 (England and Wales)









MEDYCLE LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2025






MEDYCLE LIMITED (REGISTERED NUMBER: 12274820)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


MEDYCLE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2025







DIRECTOR: Dr S J Johnson





SECRETARY: Dr S J Johnson





REGISTERED OFFICE: Flat 12, Infinity
45-47 Boscombe Overcliff Drive
Southbourne
Dorset
BH5 2EB





REGISTERED NUMBER: 12274820 (England and Wales)





ACCOUNTANTS: Morris Crocker
Chartered Accountants
Station House
North Street
Havant
Hampshire
PO9 1QU

MEDYCLE LIMITED (REGISTERED NUMBER: 12274820)

BALANCE SHEET
31 JANUARY 2025

2025 2024
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 233 666
Investment property 5 221,118 221,118
221,351 221,784

CURRENT ASSETS
Debtors 6 7,125 3,439
Cash at bank 15,012 9,004
22,137 12,443
CREDITORS
Amounts falling due within one year 7 169,627 142,507
NET CURRENT LIABILITIES (147,490 ) (130,064 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

73,861

91,720

CREDITORS
Amounts falling due after more than one
year

8

-

40,178
NET ASSETS 73,861 51,542

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 73,761 51,442
SHAREHOLDERS' FUNDS 73,861 51,542

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MEDYCLE LIMITED (REGISTERED NUMBER: 12274820)

BALANCE SHEET - continued
31 JANUARY 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 3 May 2025 and were signed by:





Dr S J Johnson - Director


MEDYCLE LIMITED (REGISTERED NUMBER: 12274820)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025

1. STATUTORY INFORMATION

Medycle Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 33.33% on cost
Computer equipment - 33.33% on cost

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties and investments in non-puttable ordinary shares.

Trade and other debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, deposits with banks and other short-term highly liquid investments and bank overdrafts. In the balance sheet, bank overdrafts are shown within borrowings or current liabilities.

Trade and other creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

MEDYCLE LIMITED (REGISTERED NUMBER: 12274820)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2025

2. ACCOUNTING POLICIES - continued

Going concern
The company has the continued financial support of its director, who has agreed not to request repayment of their loan until the company has the funds available. The mortgages are repayable in more than five years, by which time it is anticipated that the company will be in a position to make the repayments. On this basis the director considers it appropriate to prepare accounts on the going concern basis. The financial statements do not include any adjustments that would result in the company suffering further trading losses.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 February 2024
and 31 January 2025 1,473 1,598 3,071
DEPRECIATION
At 1 February 2024 1,473 932 2,405
Charge for year - 433 433
At 31 January 2025 1,473 1,365 2,838
NET BOOK VALUE
At 31 January 2025 - 233 233
At 31 January 2024 - 666 666

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 February 2024
and 31 January 2025 221,118
NET BOOK VALUE
At 31 January 2025 221,118
At 31 January 2024 221,118

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 3,253 2,893
Other debtors 3,872 546
7,125 3,439

MEDYCLE LIMITED (REGISTERED NUMBER: 12274820)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Taxation and social security 5,415 6,411
Other creditors 164,212 136,096
169,627 142,507

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Other creditors - 40,178